This recall affects America’s most prescribed drug. It’s the latest in a series of concerning manufacturing issues that have ...
ImmunityBio jumped by 7.76 percent on Friday to close at $2.36 apiece after securing the green light of the European ...
As per previous communication, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) had informed Anavex about a negative trend-vote following its oral examination in ...
The move broadens treatment choices for pediatric patients aged 10 years and older whose diabetes remains uncontrolled with ...
EMA issues positive opinion on Novo Nordisk's higher-dose Wegovy, supported by strong weight-loss data and ongoing reviews in ...
Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.
EMA recommends conditional authorization for ImmunityBio's Anktiva with BCG after a 71% complete response rate in ...
The European Medicines Agency's committee on Friday recommended a change to extend the use of Eli Lilly's blockbuster ...
Novo Nordisk A/S said its high-dose version of blockbuster Wegovy has been cleared by the European Union’s drug advisory board, opening the way for use of a shot that delivers more weight loss than ...
GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...
The European Medicines Agency's committee on Friday recommended extending the use of Eli Lilly's blockbuster drug Mounjaro ...
An expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed seven new medicines for approval this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback